WATSON 3211 WATSON 3211 (Rivastigmine Tartrate 6 mg)
Pill with imprint WATSON 3211 WATSON 3211 is Brown & Orange, Capsule-shape and has been identified as Rivastigmine Tartrate 6 mg. It is supplied by Watson Pharmaceuticals.
Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 6 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 3211 WATSON 3211
Rivastigmine Tartrate
- Imprint
- WATSON 3211 WATSON 3211
- Strength
- 6 mg
- Color
- Brown & Orange
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- Inactive Ingredients
-
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
gelatin,
titanium dioxide,
ferric oxide yellow,
ferric oxide red,
ferrosoferric oxide,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
indigotindisulfonate sodium,
FD&C Red No. 40,
shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-3211 (Discontinued) | Watson Pharmaceuticals, Inc. |
| 63739-0579 | McKesson Packaging Services |
More about rivastigmine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- 33 Reviews
- Drug class: cholinesterase inhibitors
Patient resources
- Drug Information
- Rivastigmine transdermal
- Rivastigmine (Advanced Reading)
- Rivastigmine Transdermal (Advanced Reading)
- Rivastigmine Capsules
- Other brands
- Exelon
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.